Literature DB >> 10235495

Zygomycosis due to Apophysomyces elegans: report of 2 cases and review of the literature.

M Kimura1, M B Smith, M R McGinnis.   

Abstract

OBJECTIVE: The zygomycete Apophysomyces elegans is an unusual human pathogen that is being reported with increasing frequency as a cause of infection in previously healthy patients following trauma or after invasive procedures. We report 2 cases of infection caused by this emerging fungal pathogen.
METHODS: Histologic sections of tissue removed from the infected patients and the isolates in culture were examined. Other infections caused by A. elegans that have been reported in the literature were reviewed.
RESULTS: Both patients developed infection due to A. elegans after sustaining trauma that required tissue debridement because of tissue necrosis. Histologic examination showed broad, sparsely septate, thin-walled hyphae and angioinvasion with thrombosis. Extensive coagulation necrosis of surrounding tissue was seen. A rapidly growing mold with sporangiophores having funnel-shaped apophyses and pyriform sporangia, characteristic of A. elegans, was isolated from each case.
CONCLUSION: Apophysomyces elegans is an opportunistic pathogen that can cause infection in previously healthy patients who suffer an injury to the cutaneous barrier, such as trauma or burns. Infection with this zygomycete should be considered when there is progressive necrosis of a wound in a previously healthy patient. Successful treatment requires tissue debridement and amphotericin B. Histologic examination for early diagnosis and frozen section evaluation of surgical margins are required for optimal therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10235495     DOI: 10.5858/1999-123-0386-ZDTAE

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 3.  Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.

Authors:  Kimberly P Liang; Imad M Tleyjeh; Walter R Wilson; Glenn D Roberts; Zelalem Temesgen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 4.  Posttraumatic mucormycosis: a nationwide study in France and review of the literature.

Authors:  Lucie Lelievre; Dea Garcia-Hermoso; Hendy Abdoul; Mickael Hivelin; Taieb Chouaki; Dominique Toubas; Anne-Claire Mamez; Laurent Lantieri; Olivier Lortholary; Fanny Lanternier
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

5.  Apophysomyces jiangsuensis sp. nov., a Salt Tolerant and Phosphate-Solubilizing Fungus from the Tidelands of Jiangsu Province of China.

Authors:  Siyu Li; Ruiming Han; Huanshi Zhang; Yongchun Song; Fugeng Zhao; Pei Qin
Journal:  Microorganisms       Date:  2020-11-26

Review 6.  Global Cutaneous Mucormycosis: A Systematic Review.

Authors:  Anna Skiada; Maria Drogari-Apiranthitou; Ioannis Pavleas; Eirini Daikou; George Petrikkos
Journal:  J Fungi (Basel)       Date:  2022-02-16

7.  Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011.

Authors:  Kizee A Etienne; John Gillece; Remy Hilsabeck; Jim M Schupp; Rebecca Colman; Shawn R Lockhart; Lalitha Gade; Elizabeth H Thompson; Deanna A Sutton; Robyn Neblett-Fanfair; Benjamin J Park; George Turabelidze; Paul Keim; Mary E Brandt; Eszter Deak; David M Engelthaler
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.